Clinical Trial Update: Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating vorolanib in combination with atezolizumab as maintenance therapy for extensive-stage small cell lung cancer has been terminated, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Tecentriq (atezolizumab)
• Vorolanib (vorolanib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-06-02